Immune receptor LAG3 regulates microglia function during Alzheimer's disease

Andrew T Perl1, Juan Wu2, John D Dong2

  • 1Neurobiology Laboratory, National Institute of Environmental Health Sciences, NIH, DHHS, Research Triangle Park, NC 27709, United States; University of Virginia, Charlottesville, VA 22903, United States.

Summary

Deleting lymphocyte activation gene 3 (Lag3) in Alzheimer's disease (AD) models reduces neurodegeneration markers and improves behavior. This suggests Lag3 is a potential therapeutic target for AD treatment.